TCBIO logo

Texas Capital Bancshares (TCBIO)

Profile

Full Name

Texas Capital Bancshares, Inc.

Ticker Symbol

TCBIO

Exchange

NASDAQ

Sector

Financial Services

Industry

Banks - Regional

Country

United States

IPO

March 26, 2021

Indexes

Not included

Website

http://www.texascapitalbank.com

Employees

1818

Key Details

Price

$21.05(-0.94%)

Market cap

-

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$932.35M(-13.31% YoY)

Annual EPS

-

PE ratio

-

Next earnings date

N/A

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $21.05
    TCBIO price is $21.05

    30-Day Relative Volume

    5.11
    TCBIO 30-day relative volume is 5.11

    Price Performance

    Price Most recent change

    -0.94%
    TCBIO price was down -0.94% on Jul 1, 2025

    Price YTD change

    +8.34%
    TCBIO price is up +8.34% since January 1st

    Price 1-year change

    +10.32%
    TCBIO price is up +10.32% year-on-year

    Price 3-year change

    -1.45%
    TCBIO price is down -1.45% over the past 3 years

    Price Range

    Price All-time high

    $28.90
    TCBIO price is currently -27.16% below its historical high of $28.90

    Price 3-year low

    $12.00
    TCBIO price is currently +75.42% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    -
    TCBIO market capitalization value is unknown

    Market cap 3-year change

    -
    TCBIO market capitalization 3-year change is unknown

    Market cap All-time high

    -
    TCBIO market capitalization all-time high is unknown

    Market cap sector rank

    -
    TCBIO market capitalization is unknown

    Shares Outstanding

    Shares Outstanding 1-Year Change

    -
    TCBIO shares outstanding 1-year change is unknown

    Shares Outstanding 3-Year Change

    -
    TCBIO shares outstanding 3-year change is unknown

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    0.23
    TCBIO beta is 0.23

    200-day SMA

    $20.53
    TCBIO price is currently +2.53% above its 200-day simple moving average

    50-day SMA

    $20.17
    TCBIO price is currently +4.35% above its 50-day simple moving average

    RSI

    65.67
    TCBIO 14-day relative strength index is 65.67

    Volume

    5.11
    TCBIO 30-day relative volume is 5.11

    ATR

    $0.34
    TCBIO average true range is $0.34

    10-day Historical Volatility

    10.49%
    TCBIO 10-day historical volatility is 10.49%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $932.35M
    TCBIO annual revenue is $932.35 million

    Revenue Analysts estimate

    $1.23B
    TCBIO annual revenue is currently -24.18% lower than the consensus analysts' forecast

    Revenue 1-year change

    -13.31%
    TCBIO annual revenue is down -13.31% year-on-year

    Revenue Sector rank

    76.27%
    TCBIO annual revenue is higher than 76.27% of companies in Financial Services sector

    EPS

    EPS

    -
    TCBIO annual earnings per share value is unknown

    EPS Analysts estimate

    -
    TCBIO annual earnings per share consensus analysts' forecast is unknown

    EPS 1-year change

    -
    TCBIO annual earnings per share 1-year change is unknown

    EPS Sector rank

    -
    TCBIO annual earnings per share is unknown

    Profit

    Gross profit

    -
    TCBIO annual gross profit value is unknown

    Gross margin

    -
    TCBIO annual gross profit margin value is unknown

    Operating profit

    -
    TCBIO annual operating income value is unknown

    Operating margin

    -
    TCBIO annual operating profit margin value is unknown

    Net income

    $77.51M
    TCBIO annual net profit is $77.51 million

    Net margin

    -
    TCBIO annual net profit margin value is unknown

    Expenses

    Total expenses

    -
    TCBIO annual total expenses value is unknown

    Operating expenses

    -
    TCBIO annual total operating expenses value is unknown

    Cost of goods sold

    -
    TCBIO annual cost of goods sold value is unknown

    Selling, general & administrative expenses

    $512.28M
    TCBIO annual SGA is $512.28 million

    Depreciation and amortization

    $54.23M
    TCBIO annual depreciation & amortization is $54.23 million

    Interest expense

    $828.25M
    TCBIO annual interest expense is $828.25 million

    Income tax

    $29.55M
    TCBIO annual income tax is $29.55 million

    EBIT & EBITDA

    EBIT

    $935.31M
    TCBIO annual earnings before interest & taxes is $935.31 million

    EBITDA

    $989.54M
    TCBIO annual EBITDA is $989.54 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $30.73B
    TCBIO annual total assets is $30.73 billion

    Non current assets

    -
    TCBIO annual long term assets value is unknown

    Current assets

    -
    TCBIO annual total current assets value is unknown

    Cash and cash equivalents

    $3.19B
    TCBIO annual cash & cash equivalents is $3.19 billion

    Accounts receivable

    -
    TCBIO annual accounts receivable value is unknown

    Inventory

    -
    TCBIO annual inventory value is unknown

    Liabilities

    Total liabilities

    $27.36B
    TCBIO annual total liabilities is $27.36 billion

    Long term liabilities

    -
    TCBIO annual total long term liabilities value is unknown

    Current liabilities

    -
    TCBIO annual total current liabilities value is unknown

    Accounts payable

    $23.68M
    TCBIO annual accounts payable is $23.68 million

    Debt

    Total debt

    $1.55B
    TCBIO annual total debt is $1.55 billion

    Total debt 1-year change

    -34.5%
    TCBIO annual total debt is down -34.5% year-on-year

    Long term debt

    $660.35M
    TCBIO annual long term debt is $660.35 million

    Short term debt

    $885.00M
    TCBIO annual short term debt is $885.00 million

    Equity & Capital

    Shareholders equity

    $3.37B
    TCBIO annual stockholders equity is $3.37 billion

    Book value

    $3.07B
    TCBIO annual book value is $3.07 billion

    Retained earnings

    $2.50B
    TCBIO annual retained earnings is $2.50 billion

    Working capital

    -
    TCBIO annual working capital value is unknown

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    $481.12M
    TCBIO annual cash flow from operations is $481.12 million

    Cash from operations 1-year change

    +28.73%
    TCBIO annual cash flow from operations is up +28.73% year-on-year

    Cash from investing

    -$2.48B
    TCBIO annual cash flow from investing activities is -$2.48 billion

    Cash from investing 1-year change

    -41.22%
    TCBIO annual cash flow from investing activities is down -41.22% year-on-year

    Cash from financing

    $1.94B
    TCBIO annual cash flow from financing activities is $1.94 billion

    Cash from financing 1-year change

    +601.44%
    TCBIO annual cash flow from financing activities is up +601.44% year-on-year

    CAPEX

    CAPEX

    $64.84M
    TCBIO annual capital expenditures is $64.84 million

    CAPEX 1-year change

    +295.83%
    TCBIO annual capital expenditures is up +295.83% year-on-year

    Free Cash Flow

    Free cash flow

    $416.28M
    TCBIO annual free cash flow is $416.28 million

    Free cash flow 1-year change

    +16.49%
    TCBIO annual free cash flow is up +16.49% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    -
    TCBIO annual gross profit margin value is unknown

    Operating margin

    -
    TCBIO annual operating profit margin value is unknown

    Net margin

    -
    TCBIO annual net profit margin value is unknown

    ROA & ROE

    ROA

    0.25%
    TCBIO annual return on assets is 0.25%

    ROE

    2.30%
    TCBIO annual return on equity is 2.30%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    -
    TCBIO price to earnings ratio value is unknown

    PE ratio Sector rank

    -
    TCBIO price to earnings ratio is unknown

    PB Ratio

    PB ratio

    -
    TCBIO price to book ratio value is unknown

    PB ratio Sector rank

    -
    TCBIO price to book ratio is unknown

    PS Ratio

    PS ratio

    -
    TCBIO price to sales ratio value is unknown

    PS ratio Sector rank

    -
    TCBIO price to sales ratio is unknown

    Enterprise value

    Enterprise value

    -
    TCBIO enterprise value value is unknown

    Enterprise value Sector rank

    -
    TCBIO enterprise value is unknown

    EV/EBITDA

    EV/EBITDA

    -
    TCBIO EV/EBITDA value is unknown

    EV/EBITDA Sector rank

    -
    TCBIO EV/EBITDA is unknown

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    -
    TCBIO annual current ratio value is unknown

    Quick ratio

    -
    TCBIO annual quick ratio value is unknown

    Leverage

    Debt to equity

    0.46
    TCBIO annual debt to equity ratio is 0.46

    Interest coverage ratio

    1.13
    TCBIO annual interest coverage ratio is 1.13

    Risk & Stability

    Piotroski F-Score

    -
    TCBIO piotroski f-score value is unknown

    Altman Z-Score

    -
    TCBIO altman z-score value is unknown

    Analyst ratings

    Recent major analysts updates

    Oct 20, 23 Raymond James
    Strong Buy
    Oct 20, 23 RBC Capital
    Sector Perform
    Sep 27, 23 Truist Securities
    Buy
    Jul 21, 23 Wedbush
    Neutral
    Jul 21, 23 Raymond James
    Strong Buy
    Jun 29, 23 Truist Securities
    Buy
    Apr 24, 23 UBS
    Sell
    Apr 24, 23 Truist Securities
    Buy
    Apr 21, 23 Wedbush
    Neutral
    Apr 21, 23 Stephens & Co.
    Overweight

    Institutional Ownership

    Screeners with TCBIO included

    US stocks
    NASDAQ Dividend Calendar
    All stocks
    Financial services sector
    NASDAQ Listed Companies
    Ex Dividend dates calendar
    Stocks with low beta
    Regional banks industry
    Stocks above SMA 200
    NASDAQ earnings calendar
    • What is the ticker symbol for Texas Capital Bancshares?
    • Does Texas Capital Bancshares pay dividends?
    • What sector is Texas Capital Bancshares in?
    • What industry is Texas Capital Bancshares in?
    • What country is Texas Capital Bancshares based in?
    • When did Texas Capital Bancshares go public?
    • Is Texas Capital Bancshares in the S&P 500?
    • Is Texas Capital Bancshares in the NASDAQ 100?
    • Is Texas Capital Bancshares in the Dow Jones?
    • When does Texas Capital Bancshares report earnings?

    What is the ticker symbol for Texas Capital Bancshares?

    The ticker symbol for Texas Capital Bancshares is NASDAQ:TCBIO

    Does Texas Capital Bancshares pay dividends?

    No, Texas Capital Bancshares does not pay dividends

    What sector is Texas Capital Bancshares in?

    Texas Capital Bancshares is in the Financial Services sector

    What industry is Texas Capital Bancshares in?

    Texas Capital Bancshares is in the Banks - Regional industry

    What country is Texas Capital Bancshares based in?

    Texas Capital Bancshares is headquartered in United States

    When did Texas Capital Bancshares go public?

    Texas Capital Bancshares's initial public offering (IPO) was on March 26, 2021

    Is Texas Capital Bancshares in the S&P 500?

    No, Texas Capital Bancshares is not included in the S&P 500 index

    Is Texas Capital Bancshares in the NASDAQ 100?

    No, Texas Capital Bancshares is not included in the NASDAQ 100 index

    Is Texas Capital Bancshares in the Dow Jones?

    No, Texas Capital Bancshares is not included in the Dow Jones index

    When does Texas Capital Bancshares report earnings?

    The date for Texas Capital Bancshares's next earnings report has not been announced yet
    On this page